Transmural Systems
Transmural has successfully leveraged over $10 million in SBIR funding to advance development of new innovative medical devices that address unmet…
AstraZeneca
EGC supported AstraZeneca in securing over $8 million in NIH funding to advance its first-in-class therapeutic candidate into a Phase 2 clinical…
AgroSpheres
AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor…
Winsantor
Winsantor has secured over $14.3 million in non-dilutive NIH funding since 2014, enabling breakthroughs in neuropathy treatment and advancing to…
Kepley Biosystems
Kepley Biosystems Thrives with EGC’s Expert Accounting, Advancing Sustainable Technologies Since 2015.
InnAVasc
InnAVasc Medical acquired by W. L. Gore & Associates following $2M in NIH funding.
Lightengale
Lightengale's novel intravenous tubing system recognized by FDA, NIH, and NSF.
Bezwada Biomedical
Bezwada Biomedical has secured $1.225 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Scioto Biosciences
Scioto Biosciences secures >$2.5M in NIH funding, attracting a $26.5M Series B investment.
Dignify Therapeutics
Dignify Therapeutics has secured >$20M in funding to assist in the development of their therapeutics for people with spinal cord injuries.
Ascent Integrated Tech
Securing over $2.8M in funding, Ascent Integrated Tech developed a system to monitor firefighters' health and environment.
Laser Thermal
Laser Thermal has secured an Air Force SBIR Phase I award ($150K), a DARPA SBIR Direct to Phase II award ($2M), and an Army STTR Phase I ($250K).
Accelerating development of innovative technologies
EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.